Endometriosis Market Report

Europe Endometriosis Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 08, 2019
  • PAGES：150
  • REPORT CODE：GMM369623
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Endometriosis market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Endometriosis Market Segmentations:

    By Player:

    • Bayer AG

    • AbbVie Co., ltd.

    • Debiopharm

    • AstraZeneca Pharmaceutical Company Limited

    • Ogeda S.A.

    • Bayer Ag

    • Teva Pharmaceutical Industries ltd.

    • Elexopharm

    • Kissei Pharmaceutical, Inc.

    • Abbott

    • Abbvie Inc.

    • Obseva SA

    • Meditrina Pharmaceuticals

    • Ipsen

    • EndoCeutics Group

    • Sanofi

    • Philogen

    • Repros Therapeutics Inc.

    • Valirx

    • Takeda, Inc.

    • Allergan

    • Myovant Sciences ltd.

    • Orphagen Pharmaceuticals, inc.

    • Evestra, Inc.

    • Astrazeneca

    • Forendo Pharma Inc.

    By Type:

    • Ultrasound

    • Pelvic exam

    • Laparoscopy

    • Magnetic Resonance Imaging (MRI)

    • Hysteroscopy

    • Sonohysterography

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Endometriosis Market Size and Growth Rate of Ultrasound from 2014 to 2026

    • 1.3.2 Europe Endometriosis Market Size and Growth Rate of Pelvic exam from 2014 to 2026

    • 1.3.3 Europe Endometriosis Market Size and Growth Rate of Laparoscopy from 2014 to 2026

    • 1.3.4 Europe Endometriosis Market Size and Growth Rate of Magnetic Resonance Imaging (MRI) from 2014 to 2026

    • 1.3.5 Europe Endometriosis Market Size and Growth Rate of Hysteroscopy from 2014 to 2026

    • 1.3.6 Europe Endometriosis Market Size and Growth Rate of Sonohysterography from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Endometriosis Market Size and Growth Rate of Hospitals from 2014 to 2026

    • 1.4.2 Europe Endometriosis Market Size and Growth Rate of Clinics from 2014 to 2026

    • 1.4.3 Europe Endometriosis Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Endometriosis Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Endometriosis by Major Types

      • 3.4.1 Market Size and Growth Rate of Ultrasound

      • 3.4.2 Market Size and Growth Rate of Pelvic exam

      • 3.4.3 Market Size and Growth Rate of Laparoscopy

      • 3.4.4 Market Size and Growth Rate of Magnetic Resonance Imaging (MRI)

      • 3.4.5 Market Size and Growth Rate of Hysteroscopy

      • 3.4.6 Market Size and Growth Rate of Sonohysterography

    4 Segmentation of Endometriosis Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Endometriosis by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Endometriosis for Hospitals

      • 4.4.2 Market Size and Growth Rate of Endometriosis for Clinics

      • 4.4.3 Market Size and Growth Rate of Endometriosis for Research Institutes

    5 Market Analysis by Major Regions

    • 5.1 Europe Endometriosis Production Analysis by Top Regions

    • 5.2 Europe Endometriosis Consumption Analysis by Top Regions

    • 5.3 Europe Endometriosis Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.3 France Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Production, Import, Consumption and Export Analysis

    6 Product Circulation of Endometriosis Market among Top Countries

    • 6.1 Top 5 Export Countries in Endometriosis Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Endometriosis Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Endometriosis Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Endometriosis Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Endometriosis Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Endometriosis Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Endometriosis Landscape Analysis

    • 7.1 Germany Endometriosis Landscape Analysis by Major Types

    • 7.2 Germany Endometriosis Landscape Analysis by Major End-Users

    8. UK Endometriosis Landscape Analysis

    • 8.1 UK Endometriosis Landscape Analysis by Major Types

    • 8.2 UK Endometriosis Landscape Analysis by Major End-Users

    9. France Endometriosis Landscape Analysis

    • 9.1 France Endometriosis Landscape Analysis by Major Types

    • 9.2 France Endometriosis Landscape Analysis by Major End-Users

    10. Italy Endometriosis Landscape Analysis

    • 10.1 Italy Endometriosis Landscape Analysis by Major Types

    • 10.2 Italy Endometriosis Landscape Analysis by Major End-Users

    11. Spain Endometriosis Landscape Analysis

    • 11.1 Spain Endometriosis Landscape Analysis by Major Types

    • 11.2 Spain Endometriosis Landscape Analysis by Major End-Users

    12. Poland Endometriosis Landscape Analysis

    • 12.1 Poland Endometriosis Landscape Analysis by Major Types

    • 12.2 Poland Endometriosis Landscape Analysis by Major End-Users

    13. Russia Endometriosis Landscape Analysis

    • 13.1 Russia Endometriosis Landscape Analysis by Major Types

    • 13.2 Russia Endometriosis Landscape Analysis by Major End-Users

    14. Switzerland Endometriosis Landscape Analysis

    • 14.1 Switzerland Endometriosis Landscape Analysis by Major Types

    • 14.2 Switzerland Endometriosis Landscape Analysis by Major End-Users

    15. Turkey Endometriosis Landscape Analysis

    • 15.1 Turkey Endometriosis Landscape Analysis by Major Types

    • 15.2 Turkey Endometriosis Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Landscape Analysis by Top Countries

      • 16.3.1 Denmark Endometriosis Market Volume and Growth Rate

      • 16.3.2 Finland Endometriosis Market Volume and Growth Rate

      • 16.3.3 Norway Endometriosis Market Volume and Growth Rate

      • 16.3.4 Sweden Endometriosis Market Volume and Growth Rate

      • 16.3.6 Iceland Endometriosis Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Landscape Analysis by Top Countries

      • 17.3.1 Belgium Endometriosis Market Volume and Growth Rate

      • 17.3.2 Netherlands Endometriosis Market Volume and Growth Rate

      • 17.3.3 Luxembourg Endometriosis Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Landscape Analysis by Top Countries

      • 18.3.1 Estonia Endometriosis Market Volume and Growth Rate

      • 18.3.2 Latvia Endometriosis Market Volume and Growth Rate

      • 18.3.3 Lithuania Endometriosis Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Bayer AG

      • 19.1.1 Bayer AG Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 AbbVie Co., ltd.

      • 19.2.1 AbbVie Co., ltd. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Debiopharm

      • 19.3.1 Debiopharm Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 AstraZeneca Pharmaceutical Company Limited

      • 19.4.1 AstraZeneca Pharmaceutical Company Limited Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Ogeda S.A.

      • 19.5.1 Ogeda S.A. Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Bayer Ag

      • 19.6.1 Bayer Ag Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Teva Pharmaceutical Industries ltd.

      • 19.7.1 Teva Pharmaceutical Industries ltd. Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Elexopharm

      • 19.8.1 Elexopharm Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Kissei Pharmaceutical, Inc.

      • 19.9.1 Kissei Pharmaceutical, Inc. Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Abbott

      • 19.10.1 Abbott Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Abbvie Inc.

      • 19.11.1 Abbvie Inc. Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Obseva SA

      • 19.12.1 Obseva SA Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Meditrina Pharmaceuticals

      • 19.13.1 Meditrina Pharmaceuticals Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Ipsen

      • 19.14.1 Ipsen Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 EndoCeutics Group

      • 19.15.1 EndoCeutics Group Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Sanofi

      • 19.16.1 Sanofi Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Philogen

      • 19.17.1 Philogen Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Repros Therapeutics Inc.

      • 19.18.1 Repros Therapeutics Inc. Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Valirx

      • 19.19.1 Valirx Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Takeda, Inc.

      • 19.20.1 Takeda, Inc. Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Allergan

      • 19.21.1 Allergan Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Myovant Sciences ltd.

      • 19.22.1 Myovant Sciences ltd. Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Orphagen Pharmaceuticals, inc.

      • 19.23.1 Orphagen Pharmaceuticals, inc. Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Evestra, Inc.

      • 19.24.1 Evestra, Inc. Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Astrazeneca

      • 19.25.1 Astrazeneca Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 Forendo Pharma Inc.

      • 19.26.1 Forendo Pharma Inc. Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    The List of Tables and Figures (Totals 107 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Europe Endometriosis Market Size and Growth Rate of Ultrasound from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Pelvic exam from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Laparoscopy from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Magnetic Resonance Imaging (MRI) from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Hysteroscopy from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Sonohysterography from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Europe Endometriosis Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • Figure Germany Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure UK Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure France Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Endometriosis Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Endometriosis Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Endometriosis

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Endometriosis by Different Types from 2014 to 2026

    • Table Consumption Share of Endometriosis by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Ultrasound

    • Figure Market Size and Growth Rate of Pelvic exam

    • Figure Market Size and Growth Rate of Laparoscopy

    • Figure Market Size and Growth Rate of Magnetic Resonance Imaging (MRI)

    • Figure Market Size and Growth Rate of Hysteroscopy

    • Figure Market Size and Growth Rate of Sonohysterography

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Endometriosis by Different End-Users from 2014 to 2026

    • Table Consumption Share of Endometriosis by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Research Institutes

    • Table Europe Endometriosis Production by Major Regions

    • Table Europe Endometriosis Production Share by Major Regions

    • Figure Europe Endometriosis Production Share by Major Countries and Regions in 2014

    • Table Europe Endometriosis Consumption by Major Regions

    • Table Europe Endometriosis Consumption Share by Major Regions

    • Table Germany Endometriosis Production, Import, Consumption and Export Analysis

    • Table UK Endometriosis Production, Import, Consumption and Export Analysis

    • Table France Endometriosis Production, Import, Consumption and Export Analysis

    • Table Italy Endometriosis Production, Import, Consumption and Export Analysis

    • Table Spain Endometriosis Production, Import, Consumption and Export Analysis

    • Table Poland Endometriosis Production, Import, Consumption and Export Analysis

    • Table Russia Endometriosis Production, Import, Consumption and Export Analysis

    • Table Switzerland Endometriosis Production, Import, Consumption and Export Analysis

    • Table Turkey Endometriosis Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Endometriosis Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Endometriosis Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Endometriosis Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Endometriosis Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Endometriosis Consumption by Types from 2014 to 2026

    • Table Germany Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Germany Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Germany Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table UK Endometriosis Consumption by Types from 2014 to 2026

    • Table UK Endometriosis Consumption Share by Types from 2014 to 2026

    • Table UK Endometriosis Consumption by End-Users from 2014 to 2026

    • Table UK Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table France Endometriosis Consumption by Types from 2014 to 2026

    • Table France Endometriosis Consumption Share by Types from 2014 to 2026

    • Table France Endometriosis Consumption by End-Users from 2014 to 2026

    • Table France Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Italy Endometriosis Consumption by Types from 2014 to 2026

    • Table Italy Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Italy Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Italy Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Spain Endometriosis Consumption by Types from 2014 to 2026

    • Table Spain Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Spain Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Spain Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Poland Endometriosis Consumption by Types from 2014 to 2026

    • Table Poland Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Poland Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Poland Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Russia Endometriosis Consumption by Types from 2014 to 2026

    • Table Russia Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Russia Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Russia Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Endometriosis Consumption by Types from 2014 to 2026

    • Table Switzerland Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Switzerland Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Switzerland Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Endometriosis Consumption by Types from 2014 to 2026

    • Table Turkey Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Turkey Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Turkey Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Endometriosis Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Endometriosis Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Endometriosis Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Endometriosis Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of AbbVie Co., ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Co., ltd.

    • Figure Sales and Growth Rate Analysis of AbbVie Co., ltd.

    • Figure Revenue and Market Share Analysis of AbbVie Co., ltd.

    • Table Product and Service Introduction of AbbVie Co., ltd.

    • Table Company Profile and Development Status of Debiopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm

    • Figure Sales and Growth Rate Analysis of Debiopharm

    • Figure Revenue and Market Share Analysis of Debiopharm

    • Table Product and Service Introduction of Debiopharm

    • Table Company Profile and Development Status of AstraZeneca Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of AstraZeneca Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of AstraZeneca Pharmaceutical Company Limited

    • Table Product and Service Introduction of AstraZeneca Pharmaceutical Company Limited

    • Table Company Profile and Development Status of Ogeda S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ogeda S.A.

    • Figure Sales and Growth Rate Analysis of Ogeda S.A.

    • Figure Revenue and Market Share Analysis of Ogeda S.A.

    • Table Product and Service Introduction of Ogeda S.A.

    • Table Company Profile and Development Status of Bayer Ag

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Ag

    • Figure Sales and Growth Rate Analysis of Bayer Ag

    • Figure Revenue and Market Share Analysis of Bayer Ag

    • Table Product and Service Introduction of Bayer Ag

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries ltd.

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries ltd.

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries ltd.

    • Table Product and Service Introduction of Teva Pharmaceutical Industries ltd.

    • Table Company Profile and Development Status of Elexopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elexopharm

    • Figure Sales and Growth Rate Analysis of Elexopharm

    • Figure Revenue and Market Share Analysis of Elexopharm

    • Table Product and Service Introduction of Elexopharm

    • Table Company Profile and Development Status of Kissei Pharmaceutical, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kissei Pharmaceutical, Inc.

    • Figure Sales and Growth Rate Analysis of Kissei Pharmaceutical, Inc.

    • Figure Revenue and Market Share Analysis of Kissei Pharmaceutical, Inc.

    • Table Product and Service Introduction of Kissei Pharmaceutical, Inc.

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Abbvie Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie Inc.

    • Figure Sales and Growth Rate Analysis of Abbvie Inc.

    • Figure Revenue and Market Share Analysis of Abbvie Inc.

    • Table Product and Service Introduction of Abbvie Inc.

    • Table Company Profile and Development Status of Obseva SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Obseva SA

    • Figure Sales and Growth Rate Analysis of Obseva SA

    • Figure Revenue and Market Share Analysis of Obseva SA

    • Table Product and Service Introduction of Obseva SA

    • Table Company Profile and Development Status of Meditrina Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meditrina Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Meditrina Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Meditrina Pharmaceuticals

    • Table Product and Service Introduction of Meditrina Pharmaceuticals

    • Table Company Profile and Development Status of Ipsen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen

    • Figure Sales and Growth Rate Analysis of Ipsen

    • Figure Revenue and Market Share Analysis of Ipsen

    • Table Product and Service Introduction of Ipsen

    • Table Company Profile and Development Status of EndoCeutics Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EndoCeutics Group

    • Figure Sales and Growth Rate Analysis of EndoCeutics Group

    • Figure Revenue and Market Share Analysis of EndoCeutics Group

    • Table Product and Service Introduction of EndoCeutics Group

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Philogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Philogen

    • Figure Sales and Growth Rate Analysis of Philogen

    • Figure Revenue and Market Share Analysis of Philogen

    • Table Product and Service Introduction of Philogen

    • Table Company Profile and Development Status of Repros Therapeutics Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Repros Therapeutics Inc.

    • Figure Sales and Growth Rate Analysis of Repros Therapeutics Inc.

    • Figure Revenue and Market Share Analysis of Repros Therapeutics Inc.

    • Table Product and Service Introduction of Repros Therapeutics Inc.

    • Table Company Profile and Development Status of Valirx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valirx

    • Figure Sales and Growth Rate Analysis of Valirx

    • Figure Revenue and Market Share Analysis of Valirx

    • Table Product and Service Introduction of Valirx

    • Table Company Profile and Development Status of Takeda, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda, Inc.

    • Figure Sales and Growth Rate Analysis of Takeda, Inc.

    • Figure Revenue and Market Share Analysis of Takeda, Inc.

    • Table Product and Service Introduction of Takeda, Inc.

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Myovant Sciences ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myovant Sciences ltd.

    • Figure Sales and Growth Rate Analysis of Myovant Sciences ltd.

    • Figure Revenue and Market Share Analysis of Myovant Sciences ltd.

    • Table Product and Service Introduction of Myovant Sciences ltd.

    • Table Company Profile and Development Status of Orphagen Pharmaceuticals, inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orphagen Pharmaceuticals, inc.

    • Figure Sales and Growth Rate Analysis of Orphagen Pharmaceuticals, inc.

    • Figure Revenue and Market Share Analysis of Orphagen Pharmaceuticals, inc.

    • Table Product and Service Introduction of Orphagen Pharmaceuticals, inc.

    • Table Company Profile and Development Status of Evestra, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evestra, Inc.

    • Figure Sales and Growth Rate Analysis of Evestra, Inc.

    • Figure Revenue and Market Share Analysis of Evestra, Inc.

    • Table Product and Service Introduction of Evestra, Inc.

    • Table Company Profile and Development Status of Astrazeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca

    • Figure Sales and Growth Rate Analysis of Astrazeneca

    • Figure Revenue and Market Share Analysis of Astrazeneca

    • Table Product and Service Introduction of Astrazeneca

    • Table Company Profile and Development Status of Forendo Pharma Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Forendo Pharma Inc.

    • Figure Sales and Growth Rate Analysis of Forendo Pharma Inc.

    • Figure Revenue and Market Share Analysis of Forendo Pharma Inc.

    • Table Product and Service Introduction of Forendo Pharma Inc.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US